热门资讯> 正文
Pulmatrix GAAP每股收益为-0.29美元
2026-08-13 20:17
- Pulmatrix press release (PULM): Q2 GAAP EPS of -$0.29.
- The Company's total cash and cash equivalents balance as of June 30, 2026, was $2.2 million, in addition to $0.7 million in restricted cash that would become unrestricted following consummation of the Merger, as compared to $4.1 million as of December 31, 2025.
More on Pulmatrix
- Historical earnings data for Pulmatrix
- Financial information for Pulmatrix
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。